78775-11-8

Basic information

• Product Name: 4-BROMO-3-METHYL-BENZALDEHYDE
• Synonyms: 4-BROMO-3-METHYL-BENZALDEHYDE;Benzaldehyde,4-broMo-3-Methyl-;4-BroMo-3-Methylbenzaldehyde, 95+%
• CAS NO: 78775-11-8
• Molecular Formula: C₈H₇BrO
• Molecular Weight: 199.04
• Mol File: 78775-11-8.mol
• Article Data: 22

Chemical Properties

• Melting Point: 114-116℃
• Boiling Point: 262℃
• Flash Point: 96℃
• Appearance: /
• Density: 1.490
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: Acetonitrle (Sparingly), Chloroform (Slightly), DMSO (Sparingly), Methanol (Spar
• Stability: Air Sensitive
• CAS DataBase Reference: 4-BROMO-3-METHYL-BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-METHYL-BENZALDEHYDE(78775-11-8)
• EPA Substance Registry System: 4-BROMO-3-METHYL-BENZALDEHYDE(78775-11-8)

Safety Data

• Hazardous Substances Data: 78775-11-8(Hazardous Substances Data)

Usage

Uses

4-Bromo-3-methylbenzaldehyde can be involved in determining conformational landscape of σ and π coupling Using para-phenylene and "Aviram-Ratner" bridges. Tetrahydroquinoline derivatives as opioid receptor antagonists.

Upstream product

• 41963-20-6 4-bromo-3-methylbenzonirtile 
• 75-17-2 formaldoxime 
• 6933-10-4 amino-5-bromo-2-toluene 
• 583-70-0 1-bromo-2,4-dimethylbenzene 
• 108-38-3 m-xylene 
• 537-92-8 3-Methylacetanilide 
• 7697-28-1 4-bromo-3-methylbenzoic acid 
• 148547-19-7 4-Bromo-3-methylbenzoic acid methyl ester 
• 149104-89-2 4-bromo-3-methylbenzylalcohol 

Downstream Products

• 146308-28-3 2-(4'-bromo-3'-methylphenyl)-5,5-dimethyl-1,3-dioxane 
• 877064-90-9 methyl (E)-3-(4-bromo-3-methylphenyl)acrylate 
• 90560-53-5 1-bromo-2-methyl-4-vinyl-benzene 
• 180082-96-6 4-bromo-3-methylbenzaldehyde oxime 
• 1437779-65-1 3-(4-bromo-3-(bromomethyl)phenyl)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazole 
• 1437779-66-2 2-bromo-5-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)benzyl acetate 
• 1437779-67-3 5-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate 
• 1437779-21-9 5-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)benzo[c][1,2]oxaborol-1(3H)-ol 
• 1479260-10-0 4-(4-bromo-3-methylphenyl)butanoic acid 
• 149104-89-2 4-bromo-3-methylbenzylalcohol 
• 27561-51-9 1-bromo-4-(bromomethyl)-2-methylbenzene 
• 215800-25-2 2-(4-bromo-3-methyl-phenyl)acetonitrile 
• 1332698-41-5 4-[5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methylbenzoic acid 

Relevant articles and documents

A substituted benzamide isoxazoline derivative or a salt thereof as a pesticidally acceptable salt. Composition and use thereof

The invention belongs to the field of pesticides, and particularly relates to a substituted benzamide isoxazoline derivative or a salt, composition and application thereof as a pesticide acceptable salt, and the compound has the structure of the formula (

Fluorine thramine intermediate and method for preparing flumbine by using same

The invention discloses a fluororesonide intermediate and a method for preparing the same, and a fluororesonide intermediate -5. Routes include the use of m-xylene as starting materials, halogenation. Oxidation reaction The intermediate -5 is further obtained by hydroximation, cyanolation, hydrolysis reaction or cyanation, oximation, and hydrolysis reaction. As some examples of the present invention, synthetic routes were increased 2 steps from 5 steps in the prior art, but surprisingly high overall yields were obtained and the purity of intermediate -5 was significantly increased. , The starting material of the intermediate -5 is prepared from high 4 - bromo -2 - methylbenzoic acid to low-priced m-xylene, so that the cost of the intermediate -5 is greatly reduced. , The reaction condition is mild, the synthesis difficulty is low, and the environment is more environmentally friendly.

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.